Pseudomonas aeruginosa: Colony Dynamics and Adaptations

Pseudomonas aeruginosa builds colonies that function less like passive clumps of cells and more like coordinated communities with layered architecture, chemical signaling networks, and the ability to reshape their surroundings. This bacterium thrives in remarkably diverse environments, from soil and water to hospital surfaces and human lungs, and much of its success traces to the way individual cells sense surfaces, communicate with neighbors, and shift their behavior in response to changing conditions. The colony-level dynamics underlying these adaptations involve a mix of cooperative and competitive strategies that researchers are still working to untangle.

How a Colony Gets Started

Colony formation begins with individual cells detecting that they have landed on a surface. This is not a passive event. P. aeruginosa uses extracellular appendages and macromolecules to sense surface contact, which triggers changes in gene regulation that shift the cell from a free-swimming lifestyle toward biofilm development.¹ The transition is not instantaneous. Cells first attach reversibly, exploring the surface with hair-like filaments called type IV pili. These pili extend, grip the surface, and retract, pulling the cell along in a crawling motion known as twitching motility.² The retraction motor generates enough force to move a cell even against friction, and the pili themselves increase their adhesion to a surface when placed under mechanical tension, reinforcing the attachment.³

Once enough cells commit to the surface, they begin producing the sticky matrix that holds the biofilm together. The decision to switch from surface exploration to biofilm construction involves internal signaling cascades that researchers describe as a continuum of growth modes, where the bacterium calibrates its physiology to the environment it encounters.

Building the Matrix

The structural scaffold of a P. aeruginosa biofilm is built from at least three self-secreted sugar polymers: alginate, Psl, and Pel. Each contributes something different. Psl and alginate together are required for the characteristic mushroom-shaped structures seen in mature biofilms. Pel influences how tightly packed the cells are within the biofilm. Mutants that can only produce alginate, lacking both Psl and Pel, lose the ability to form biofilms entirely.⁴ The three polymers also cross-regulate one another: knocking out Psl production ramps up Pel, and losing Pel boosts alginate. This compensatory behavior suggests the bacterium maintains a certain baseline of matrix material even when one component is disrupted.

These exopolysaccharides also provide physical protection against antibiotics and create a range of microhabitats within the biofilm where cells can adopt different metabolic states.⁵

Beyond the sugar polymers, biofilm matrices contain large amounts of extracellular DNA. The source of that DNA turns out to be dramatic: a subpopulation of cells within the biofilm undergoes explosive lysis. Rod-shaped cells rapidly lose structural integrity, round up, and burst, releasing their DNA and membrane fragments into the surroundings. Tracking these events under a microscope, researchers found that all observed eDNA release events were associated with this explosive transition.⁶ The membrane fragments form vesicles that serve their own signaling and defensive purposes. Mutants unable to carry out this lysis process are defective in both vesicle production and biofilm development, suggesting that the sacrifice of a few cells is structurally important for the community.

Swarming and Surface Colonization

While twitching motility handles cell-by-cell crawling on hard surfaces, P. aeruginosa has another collective trick for soft, moist surfaces: swarming. Swarming cells use their flagella to move in coordinated groups, forming branching tendrils that radiate outward from the colony center. These tendrils are not random; they sense and respond to other groups of cells, altering their trajectories as they go.⁷

The patterns depend on surfactant molecules called rhamnolipids. These biosurfactants reduce surface tension and modify the physical properties of the substrate ahead of the advancing colony, making it easier for bacteria to move. The effect is long-range: rhamnolipids create a swelling front that extends well beyond the colony’s edge, wetting the surface and enabling collective motility across distances much larger than an individual cell could manage on its own.⁸ Mutants that cannot produce rhamnolipids swarm in altered patterns, with irregularly shaped tendrils rather than the organized branching of the wild type.

Interestingly, the importance of rhamnolipids for surface colonization depends heavily on the surface itself. On non-agar gelling agents like gellan gum, rhamnolipid-deficient mutants still spread effectively, just in a circular shape rather than a branching pattern.⁹ Modeling work has proposed that the tendril patterns arise from competition between the changing viscosity of the bacterial suspension and the outward push of surface-tension-driven forces at the colony edge.¹⁰ The visual result, branching fractal-like tendrils, looks almost artistic, but it serves a practical purpose: maximizing the area colonized per unit of effort.

Quorum Sensing and Colony Coordination

Individual cells within a P. aeruginosa colony coordinate their behavior through quorum sensing, a chemical communication system that ties gene expression to population density. The system has a layered architecture: a hierarchy of signaling circuits controls when genes for virulence, biofilm development, and surfactant production switch on. Two major circuits, the las and rhl systems, operate in a cascade where the las system activates the rhl system, which in turn drives rhamnolipid production and other collective behaviors.¹¹

Wild-type cells with functional quorum sensing produce a different extracellular protein profile than mutants lacking it. Bacteria with intact signaling are better at clumping together, more tolerant of membrane-targeting agents, and secrete hundreds more extracellular proteins during growth.¹² The signaling switch itself behaves in a surprisingly binary way: the las system is bistable, with distinct on and off states, and it shows hysteresis, a form of memory where the system’s current state depends on its history. A colony that has already switched on does not easily switch off when the signal concentration dips.¹³

Beyond the las and rhl circuits, P. aeruginosa produces a third class of signal molecule called the Pseudomonas quinolone signal (PQS). PQS does double duty: it participates in quorum sensing and it stimulates the formation of outer membrane vesicles, tiny packets of membrane that carry cargo between cells.¹⁴ PQS even mediates its own packaging and transport by driving the vesicle formation it depends on, a neat self-reinforcing loop.¹⁵

Oxygen Gradients and Metabolic Layering

A P. aeruginosa biofilm that looks homogeneous from the outside is anything but uniform on the inside. Oxygen is consumed rapidly by cells at the surface, creating steep gradients that leave deeper layers anaerobic. In colony biofilms, oxygen runs out within roughly the first 100 to 150 micrometers of depth, depending on the strain.¹⁶ Below that threshold, cells switch to alternative metabolic strategies, including denitrification, which uses nitrate instead of oxygen as a terminal electron acceptor. Surprisingly, denitrification is not confined to the oxygen-free zone. Nitrate consumption occurs throughout the colony’s depth, including in the oxygen-rich surface layers.

These chemical gradients give rise to distinct physiological subpopulations within the same biofilm.¹⁷ Cells near the surface are metabolically active and grow relatively fast. Deeper cells face starvation conditions and often enter a dormant or slow-growing state. This metabolic layering has real consequences for treatment: dormant cells in the depths of the biofilm are far harder to kill with antibiotics than their active counterparts near the surface.

The link between anaerobic conditions and chronic infection is particularly relevant in cystic fibrosis, where the thick airway mucus creates an oxygen-depleted environment. P. aeruginosa can form robust biofilms under these anaerobic conditions, relying on quorum sensing and specialized enzymes to manage the toxic byproducts of anaerobic respiration.¹⁸

Phenazines as Metabolic Lifelines

One of P. aeruginosa’s more inventive adaptations involves its blue-green pigment pyocyanin, a member of the phenazine family. Pyocyanin is not just a pigment or a toxin; it functions as an electron shuttle. In oxygen-starved layers of the biofilm, cells cannot dispose of the electrons generated by their metabolism in the usual way. Pyocyanin picks up those electrons and ferries them to locations where oxygen or another electron acceptor is available, effectively extending the biofilm’s metabolic reach.¹⁹ This process, called extracellular electron transfer, promotes survival under oxygen-limited conditions but does not support growth on its own. Other redox-active molecules that the bacterium does not produce cannot substitute, indicating that phenazines are specifically adapted for this role.

The efficiency of this shuttling gets a boost from the extracellular DNA in the biofilm matrix. Pyocyanin interacts with eDNA in a way that supports rapid electron cycling, faster than the rate at which pyocyanin diffuses out of the biofilm.²⁰ This means the eDNA released by explosive cell lysis serves a metabolic function as well as a structural one.

Researchers have explored manipulating this electron shuttle therapeutically. When an electrode is used to lock pyocyanin in its reduced state, preventing it from cycling, the number of viable cells in anaerobic biofilms drops roughly a hundredfold compared to biofilms where pyocyanin is allowed to cycle freely. Mutants that cannot produce phenazines are unaffected by the electrode, confirming that the killing effect works specifically through disrupting pyocyanin’s redox role.²¹

Persister Cells and Antibiotic Tolerance

Even within a genetically identical population, not all cells in a biofilm respond to antibiotics the same way. A subset of cells in the deepest, most nutrient-deprived layers enter a dormant state and become highly tolerant to killing. These are known as persister cells. They are not resistant in the genetic sense; if you grow them back up in fresh medium, they are just as sensitive to antibiotics as the original strain. Their tolerance comes from being metabolically inactive, which makes them invisible to drugs that target active cellular processes like cell wall synthesis or DNA replication.²²

The clinical problem this creates is straightforward: you treat a biofilm infection, kill off the active cells, and the persisters survive. When treatment ends, they wake up and repopulate the biofilm. Experiments with the antibiotic tobramycin demonstrate this pattern clearly. Treatment produces a biphasic kill curve where the active population drops quickly, but a remaining persister population resists further killing regardless of how much drug concentration is increased or how long exposure continues. When those surviving cells are regrown, their sensitivity to tobramycin is identical to the parent strain.²³ The persister fraction is larger in established biofilms than in young ones, which helps explain why chronic P. aeruginosa infections become progressively harder to clear.

Small-Colony Variants and Chronic Persistence

Beyond the temporary dormancy of persister cells, P. aeruginosa also generates more lasting phenotypic variants. Rugose small-colony variants (RSCVs) are frequently isolated from chronic infections and from laboratory biofilms. They produce wrinkled, compact colonies and have a dramatically enhanced capacity to form biofilms, driven by increased expression of the Pel and Psl polysaccharide genes. At the same time, RSCVs downregulate motility functions and show altered metabolic capabilities, including reduced growth on certain carbon sources.²⁴

The connection between RSCVs and poor clinical outcomes is not just about biofilm formation. These variants provoke a strong but ultimately ineffective immune response. In wound and lung infection models, RSCVs triggered extensive neutrophil recruitment and reactive oxygen species production, but evaded phagocytic killing. The result was significant tissue damage from the immune response itself, with higher bacterial counts persisting compared to infections with standard strains.²⁵ RSCVs also showed enhanced tolerance to hydrogen peroxide and antimicrobial peptides produced by the immune system. This combination of immune evasion, pro-inflammatory signaling, and antimicrobial tolerance helps explain the recurring tissue damage characteristic of chronic P. aeruginosa infections.

The mechanical properties of RSCV biofilms differ too. Wild-type colony biofilms are strongest early on and become weaker with age. Mucoid biofilms follow the opposite pattern, growing stronger over several days. RSCV biofilms gradually increase in strength over time, though they generally track closer to the wild type in shear resistance.²⁶

Mucoid Conversion in the Lungs

One of the most clinically significant adaptations P. aeruginosa undergoes during chronic lung infection is the switch to mucoid colony morphology, characterized by overproduction of alginate. This transition is driven overwhelmingly by mutations in a single gene called mucA, which normally keeps alginate production in check. In collections of mucoid clinical isolates from cystic fibrosis patients, about 84 percent carried mucA mutations, most of which caused the gene to produce a truncated, nonfunctional protein.²⁷ A second study of 94 strains confirmed the finding, with 82 harboring mucA mutations.²⁸

The mutations themselves are not random. The most common pathway involves single-base deletions in a short stretch of repeated G nucleotides within the mucA sequence, a type of mutation hotspot that is especially prone to error during DNA replication.²⁹ The mucoid phenotype provides a survival advantage in the lung environment, where the overproduced alginate shields bacteria from immune attack and antibiotic penetration.

Competing with Neighbors

P. aeruginosa does not exist in isolation during most infections. In chronic wounds and cystic fibrosis lungs, it frequently shares space with Staphylococcus aureus and other bacteria, and the interactions between species shape both community structure and treatment outcomes. P. aeruginosa possesses type VI secretion systems (T6SSs), molecular syringes that inject toxic proteins directly into neighboring cells. The bacterium carries three of these systems, which appear to serve different roles: one functions primarily as a weapon for killing competing bacteria, while the other two are more active during host infection.³⁰

One of these systems also provides a metabolic advantage under oxygen-free conditions by secreting a protein that scavenges molybdenum ions from the environment, an activity that boosts the bacterium’s ability to survive and compete during anaerobic growth.³¹

The relationship with S. aureus is more nuanced than simple killing. In dual-species biofilms, the two organisms coexist in close proximity, and P. aeruginosa’s Psl polysaccharide gives it a competitive edge during the early stages of biofilm formation by reducing S. aureus aggregation.³² Yet S. aureus has its own survival strategy: in P. aeruginosa-dominated biofilms, S. aureus enters a viable but non-cultivable state, essentially shutting down growth while remaining alive and even upregulating virulence genes. This dormant-but-dangerous phenotype may allow S. aureus to persist and resurface when conditions change.³³

Phage Vulnerability and Exploitation

Bacteriophages, viruses that infect bacteria, represent one of the few forces that can penetrate and disrupt P. aeruginosa biofilms. Phages can degrade the extracellular matrix, increase antibiotic penetration into deeper biofilm layers, and even interfere with quorum sensing.³⁴ Some phages appear to break down alginate directly. Experiments showed that phage-treated alginate had lower molecular weight and reduced viscosity by up to 40 percent compared to untreated samples, suggesting enzymatic degradation that clears a path through the matrix.³⁵

Phage therapy against P. aeruginosa biofilms faces real limitations, though. Dense biofilms can physically shield interior cells from phage contact. Subpopulations within the biofilm develop phage resistance, and the very quorum-sensing systems that coordinate biofilm behavior can suppress phage infection. These are not trivial obstacles, and they help explain why phage therapy for chronic P. aeruginosa infections remains experimental rather than routine.

Evolutionary Diversification Over Time

When P. aeruginosa populations grow for extended periods, whether in laboratory biofilm reactors or in a patient’s lungs, they do not simply optimize toward a single best genotype. Instead, genetic diversification occurs in parallel across the population. Long-term experimental evolution studies have found that dozens of genes accumulate parallel mutations across replicate populations, but complete selective sweeps, where one genotype takes over entirely, are rare. Instead, competing lineages coexist, each carrying different adaptive mutations in genes related to nutrient transport, signal transduction, and biofilm regulation.³⁶ This sustained diversity, maintained by clonal interference where competing beneficial mutations prevent any single lineage from dominating, gives the population as a whole a broader toolkit for responding to future environmental shifts. It is a bet-hedging strategy played out in real time across millions of bacterial generations.